全文获取类型
收费全文 | 9060篇 |
免费 | 333篇 |
国内免费 | 56篇 |
专业分类
耳鼻咽喉 | 145篇 |
儿科学 | 195篇 |
妇产科学 | 105篇 |
基础医学 | 1098篇 |
口腔科学 | 108篇 |
临床医学 | 666篇 |
内科学 | 2212篇 |
皮肤病学 | 78篇 |
神经病学 | 599篇 |
特种医学 | 505篇 |
外科学 | 1577篇 |
综合类 | 33篇 |
预防医学 | 257篇 |
眼科学 | 305篇 |
药学 | 590篇 |
中国医学 | 32篇 |
肿瘤学 | 944篇 |
出版年
2023年 | 26篇 |
2022年 | 29篇 |
2021年 | 109篇 |
2020年 | 59篇 |
2019年 | 79篇 |
2018年 | 117篇 |
2017年 | 97篇 |
2016年 | 134篇 |
2015年 | 135篇 |
2014年 | 203篇 |
2013年 | 309篇 |
2012年 | 485篇 |
2011年 | 584篇 |
2010年 | 338篇 |
2009年 | 325篇 |
2008年 | 572篇 |
2007年 | 642篇 |
2006年 | 608篇 |
2005年 | 660篇 |
2004年 | 716篇 |
2003年 | 696篇 |
2002年 | 688篇 |
2001年 | 111篇 |
2000年 | 121篇 |
1999年 | 120篇 |
1998年 | 149篇 |
1997年 | 114篇 |
1996年 | 106篇 |
1995年 | 116篇 |
1994年 | 102篇 |
1993年 | 114篇 |
1992年 | 86篇 |
1991年 | 79篇 |
1990年 | 76篇 |
1989年 | 61篇 |
1988年 | 69篇 |
1987年 | 47篇 |
1986年 | 35篇 |
1985年 | 49篇 |
1984年 | 40篇 |
1983年 | 22篇 |
1982年 | 23篇 |
1981年 | 23篇 |
1980年 | 40篇 |
1979年 | 28篇 |
1978年 | 23篇 |
1977年 | 16篇 |
1976年 | 9篇 |
1974年 | 8篇 |
1971年 | 9篇 |
排序方式: 共有9449条查询结果,搜索用时 15 毫秒
1.
2.
Sustained virologic response achieved after curative treatment of hepatitis C virus‐related hepatocellular carcinoma as an independent prognostic factor 下载免费PDF全文
Naoya Kanogawa Sadahisa Ogasawara Tetsuhiro Chiba Tomoko Saito Tenyu Motoyama Eiichiro Suzuki Yoshihiko Ooka Akinobu Tawada Tatsuo Kanda Shigeru Mikami Ryosaku Azemoto Takashi Kaiho Masami Shinozaki Masayuki Ohtsuka Masaru Miyazaki Osamu Yokosuka 《Journal of gastroenterology and hepatology》2015,30(7):1197-1204
3.
Yukitomo Ishi Shigeru Yamaguchi Michiharu Yoshida Hiroaki Motegi Hiroyuki Kobayashi Shunsuke Terasaka Kiyohiro Houkin 《Journal of neuroradiology. Journal de neuroradiologie》2021,48(4):266-270
Background and purposeMost individuals with optic pathway/hypothalamic pilocytic astrocytoma (OPHPA) harbor either the BRAF V600E mutation or KIAA1549-BRAF fusion (K-B). This study aimed to investigate the imaging characteristics of OPHPA in relation to BRAF alteration status.Materials and methodsSeven cases of OPHPA harboring either the BRAF V600E mutation or K-B fusion were included in the study. Preoperative magnetic resonance imaging (MRI) was assessed for degree of T2 hyperintensity on T2-weighted images (T2WI) and the ratio of nonenhancing T2 or fluid-attenuated inversion recovery (FLAIR) hyperintense area to the contrast enhanced area (CE) on gadolinium-enhanced-T1 weighted images (T2/FLAIR-CE mismatch). The T2 signal intensity was normalized to cerebrospinal fluid (T2/CSF) for both the V600E and K-B group and compared. T2/FLAIR-CE mismatch was assessed by calculating the proportion of the tumor volume of nonenhancing high T2 signal intensity to the whole lesion (nonenhancing and enhancing components).ResultsFour and three cases of OPHPA harboring the BRAF V600E mutation and K-B, respectively, were analyzed. The T2/CSF value was higher in the K-B group than in the V600E group. Moreover, the V600E group had a larger T2/FLAIR-CE mismatch than the K-B group.ConclusionsThe BRAF alteration status in individuals with OPHPA was associated with preoperative MRI by focusing on T2 signal intensity and T2/FLAIR-CE mismatch. The BRAF V600E mutation was associated with a lower T2/CSF value and larger T2/FLAIR-CE mismatch, whereas K-B fusion was associated with a higher T2/CSF value and smaller T2/FLAIR-CE mismatch. 相似文献
4.
5.
Tomoe Koizumi PhD Yodo Sugishita MD PhD Yuki Suzuki-Takahashi MD PhD Kazuko Nara MA Tomoko Miyagawa MA Misako Nakajima MA Kouhei Sugimoto MD PhD Manabu Futamura MD PhD Tatsuro Furui MD PhD Yasushi Takai MD PhD Hiroshi Matsumoto MD PhD Hideko Yamauchi MD Shinji Ohno MD PhD Akemi Kataoka MD PhD Kiyotaka Kawai MD PhD Eisuke Fukuma MD PhD Hiroko Nogi MD PhD Koichiro Tsugawa MD PhD Nao Suzuki MD PhD 《Cancer》2023,129(16):2568-2580
6.
Wataro TSURUTA Yuji MATSUMARU Shigeru MIYACHI Nobuyuki SAKAI 《Neurologia medico-chirurgica》2014,54(1):72-78
A subgroup analysis of spinal vascular lesions in the Japanese Registry of Neuroendovascular Therapy (JR-NET) and JR-NET2, retrospective registry studies conducted in 2005–2009, was performed to understand the current status of treatment in Japan. Of 201 spinal lesions enrolled, 98 analyzable cases of spinal dural arteriovenous fistula (SDAVF), 43 of spinal perimedullary arteriovenous fistula (SPAVF), and 23 of spinal intramedullary arteriovenous malformation (SIAVM) were assessed. Treatment was radical in the majority (83.6%) of SDAVF, palliative in the majority (70.6%) of SIAVM, and radical and palliative in a similar number of cases of SPAVF. Total occlusion was achieved in 26 (54.2%) SDAVF cases, 9 (29.0%) SPAVF, and 4 (23.5%) SIAVM. Treatment-related complications occurred in 3 (3.1%) SDAVF cases, 7 (16.3%) SPAVF, and 1 (4.3%) SIAVM. Post-treatment neurological improvement was achieved in 49 (50.0%) of SDAVF cases, 15 (34.9%) SPAVF, and 5 (21.7%) SIAVM. The modified Rankin Scale (mRS) of 0, 1, or 2 on postoperative day 30, the primary endpoint, was achieved in 62 (63.3%) SDAVF cases, 26 (60.5%) SPAVF, and 12 (52.2%) SIAVM. The mRS of 0–2 on postoperative day 30 was correlated with pre-symptomatic mRS of 0–2 [P < 0.0001, odds ratio (OR): 42.88, 95% confidence interval (CI): 14.83–123.97] and postoperative neurological improvement (P = 0.046, OR: 2.57, 95% CI: 1.02–6.48). In Japan, endovascular treatment of spinal vascular lesions was administered safely. Good mRS on postoperative day 30 was highly correlated with good pre-symptomatic mRS, suggesting necessity of early diagnosis and treatment. 相似文献
7.
8.
9.